(147 days)
Scoop-1 Catheter, Transtracheal Systems, Inc. and Transtracheal Systems, Inc. TTHF-1000 Mid Section Hose
Not Found
No
The document does not mention AI, ML, or any related concepts like image processing, training sets, or performance metrics typically associated with AI/ML algorithms. The device description focuses on the physical construction and intended use of a catheter.
Yes
The device is indicated for the "treatment of hypoxemia."
No
The device is indicated for the "treatment of hypoxemia" by delivering air/oxygen, which is a therapeutic function, not a diagnostic one.
No
The device description clearly details a physical catheter made of plastics with a radiopaque stripe, indicating it is a hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the treatment of hypoxemia by delivering a heated and humidified air/oxygen mixture directly to the patient's airway via a tracheostomy tube. This is a therapeutic intervention, not a diagnostic test performed in vitro (outside the body) on biological samples.
- Device Description: The device is a catheter designed to be inserted into a tracheostomy tube to deliver gases. This is a medical device used for direct patient care.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), detecting specific analytes, or providing diagnostic information about a patient's condition based on laboratory testing.
The device is clearly intended for direct patient treatment and falls under the category of a therapeutic medical device, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
TTCF is indicated for the treatment of hypoxemia with delivery of transtracheal high flows of a heated and humidified air/oxygen mixture to self-breathing patients with a cuff deflated fenestrated tracheostomy tube. TTCF is indicated for hospital use in adult patients.
Product codes (comma separated list FDA assigned to the subject device)
BTO
Device Description
The TTCF Catheter is constructed of clear, latex-free plastics with a radiopaque stripe for identification by x-ray. A rounded tip facilitates insertion and minimizes potential mucous irritation or injury. The catheter is 4 mm O.D. used within an adult Portex Blue Line Fenestrated Tracheostomy Tube. Inner diameter is 3.1 mm in 11.5, 13.5 and 15.5 cm lengths. The distal end is an 11 mm connector capable of attaching to the CS Medical Mid-section Hose. The catheter is supplied sterile and designed as single patient use.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Adults
Intended User / Care Setting
Hospital use
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-Clinical Data:
- Materials meet ISO 10993 for biocompatibility.
- Flow rates are comparable to the predicate and accurate.
- How faces are companse to the possible and mitigated potential hazards.
- The catheter is designed, labeled, and verified for performance and safety.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Scoop-1 Catheter, Transtracheal Systems, Inc. and Transtracheal Systems, Inc. TTHF-1000 Mid Section Hose
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 868.5800 Tracheostomy tube and tube cuff.
(a)
Identification. A tracheostomy tube and tube cuff is a device intended to be placed into a surgical opening of the trachea to facilitate ventilation to the lungs. The cuff may be a separate or integral part of the tracheostomy tube and is, when inflated, intended to establish a seal between the tracheal wall and the tracheostomy tube. The cuff is used to prevent the patient's aspiration of substances, such as blood or vomit, or to provide a means for positive-pressure ventilation of the patient. This device is made of either stainless steel or plastic.(b)
Classification. Class II.
0
510(k) Summary CS Medical Adult TTCF Catheter and Mid Section Hose
CS Medical, Inc. 6151 Songbird Circle Boulder, CO 80303 303-817-1789 303-337-5050 fax James Seiler, CEO
Prepared 6-9-05 L.W. Ward and Associates, Inc. 4655 Kirkwood Court Boulder, CO 80301 303-530-3279 303-530-4774 fax
Device Name: Transtracheal Continuous Flow (TTCF) Catheter Common Name and Classification: Tube, Tracheostomy, Class II, 868.5800 BTO Predicate Device: Scoop-1 Catheter, Transtracheal Systems, Inc. and Transtracheal Systems, Inc. TTHF-1000 Mid Section Hose
Device Description:
The TTCF Catheter is constructed of clear, latex-free plastics with a radiopaque stripe for identification by x-ray. A rounded tip facilitates insertion and minimizes potential mucous irritation or injury. The catheter is 4 mm O.D. used within an adult Portex Blue Line Fenestrated Tracheostomy Tube. Inner diameter is 3.1 mm in 11.5, 13.5 and 15.5 cm lengths. The distal end is an 11 mm connector capable of attaching to the CS Medical Mid-section Hose. The catheter is supplied sterile and designed as single patient use.
Indications for Use:
TTCF is indicated for the treatment of hypoxemia with delivery of transtracheal high flows of a heated and humidified air/oxygen mixture to self-breathing patients with a cuff deflated fenestrated tracheostomy tube. TTCF is indicated for hospital use in adult patients.
Characteristics of proposed versus predicate devices:
Intended Use: Both the CS Medical and Transtracheal catheters and hose are used for high flow supplemental oxygen for the treatment of hypoxemia. Catheters are available in three lengths. The products are intended for use in open systems.
Flow rates are comparable at 6-12 LPM for the Transtracheal and 6-15 LPM for the CS Medical device.
Both products are designed for adults.
Both catheters have radiopaque stripes used for location during x-ray. Catheters are sold sterile.
1
Differences:
Differences.
- The TTCF catheter is introduced via tracheostomy tube where the SCOOP-1 Catheter is introduced via a tracheocutaneous fistulous tract.
miroduced via a trachedualleda ilstallous track
2. The TTCF Catheter has a standard 15 mm tracheostomy tube connector where the SCOOP-1 Catheter attaches to the neck via a flange and securing necklace.
Catherer and includes to the TTCF Gas Delivery System via an 11 mm connector and 3. The Fref Catheter connector attaches to the Gas Delivery System via a standard female luer connector.
comicelor.
4. Recommended use for the TTCF Catheter is limited to 24 hours to prevent mucous build-up, 4. Recommended as 10. "Le "Le" and promote general hygiene in hospital patients versus longer periods for the predicate which is intended for use in the home.
Non-Clinical Data:
-
Materials meet ISO 10993 for biocompatibility.
-
Flow rates are comparable to the predicate and accurate.
-
How faces are companse to the possible and mitigated potential hazards.
-
The catheter is designed, labeled, and verified for performance and safety.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized eagle with three lines forming its body and wings. The eagle is enclosed in a circle, and the text "DEPARTMENT OF HEALTH AND HUMAN SERVICES - USA" is written around the circle's perimeter.
Public Health Service
JUL 1 2 2005
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
CS Medical, Incorporated c/o Lewis Ward L. W. Ward and Associates, Incorporated 4655 Kirkwood Court Boulder, Colorado 80301
Re: K050379
Trade/Device Name: Transtracheal Continuous Flow Catheter Regulation Number: 21 CFR 868.5800 Regulation Name: Tracheostomy tube and tube cuff Regulatory Class: II Product Code: BTO Dated: June 25, 2005 Received: June 27, 2005
Dear Mr. Ward:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Qur Solom fu
Chiu Lin, Ph.D.
Director Division of Anesthesiology, General Hospital Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
INDICATIONS FOR USE
510(k) Number (if known):
Device Name: Transtracheal Continuous Flow Catheter
Indications for Use:
TTCF is indicated for the treatment of hypoxemia with delivery of transtracheal high flows of a heated and humidified air/oxygen mixture to self-breathing patients with a cuff deflated fenestrated tracheostomy tube. TTCF is indicated for hospital use in adult patients.
Prescription Use x (Part 21 CFR 801 Subpart D)
AND/OR
Over-the-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Amy Julian
(Division Sign-Off) Division of Anesthesiology, General Hospital, Infection Control, Dental Devices
510(k) Number: